Piramal Pharma Resumes Operations at Gujarat Facility After Rainfall and Flooding Disruption

Piramal Pharma Resumes Operations at Gujarat Facility After Rainfall and Flooding Disruption
<h1>Piramal Pharma Resumes Operations at Gujarat Facility After Rainfall and Flooding Disruption</h1>

Piramal Pharma Limited has announced the resumption of operations across substantially all areas at its manufacturing facilities located in Ahmedabad, Gujarat, following a period of temporary suspension caused by heavy rainfall and flooding in parts of the state.

The company had previously suspended operations at its facility situated at Plot Nos. 18 and 19 PHARMEZ - Pharmaceutical Special Economic Zone, Village Matoda, Sarkhej Bawla, NH 8A, Taluka Sanand, Ahmedabad.

As of August 3, 2026, the company confirmed that operations have resumed across almost all sections of the facility. Limited restoration and recommissioning activities are currently ongoing in certain specific areas of the plant.

Piramal Pharma Limited stated that it has completed a preliminary assessment regarding the impact on its assets and operations. The company has initiated the necessary insurance claim process for the affected site. Based on the assessment conducted to date, Piramal Pharma does not anticipate any material impact on its financial performance or overall operations.

PPLPHARMA Stock Price Movement​

Piramal Pharma Limited shares edged higher to settle today, closing at ₹199.28 after gaining 1.78%. The equity registered strong activity during the day, with a total traded volume of 7.05 million shares recorded in the session.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top